NCT00400842

Brief Summary

This study is to verify the efficacy of 3.0 g/day of SA-001 in patients with pancreatic exocrine insufficiency caused by chronic pancreatitis in the non-compensatory stage or by pancreatectomy as compared with placebo under a double-blind design using the change in a coefficient of fat absorption as a primary endpoint.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
274

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started May 2007

Geographic Reach
1 country

98 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 17, 2006

Completed
6 months until next milestone

Study Start

First participant enrolled

May 1, 2007

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

July 28, 2011

Status Verified

July 1, 2011

Enrollment Period

2.3 years

First QC Date

November 16, 2006

Last Update Submit

July 27, 2011

Conditions

Keywords

SA-001Pancreatic Exocrine InsufficiencyPancreatectomy

Outcome Measures

Primary Outcomes (1)

  • Change in CFA from baseline to the end of double-blind treatment

    7 days after baseline

Secondary Outcomes (1)

  • Stool fat excretion, stool weight, stool frequency, nutritional parameters

    7 days after baseline

Study Arms (3)

L

EXPERIMENTAL
Drug: SA-001

H

EXPERIMENTAL
Drug: SA-001

P

PLACEBO COMPARATOR
Drug: Placebo

Interventions

SA-001DRUG

0.25 g of SA-001 pellets/capsule, 12 capsules/day for 7 days

L

Placebo

P

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects with chronic pancreatitis in the non-compensatory stage or pancreatectomy
  • Subjects whose CFA is 80% or less
  • Subjects who are able to be hospitalized

You may not qualify if:

  • Subjects who are judged to be difficult to have at least 40 g/day of fat intake during course of the study
  • Subjects who have a known allergy to porcine protein and/or any component of digestive enzyme preparations
  • Subjects who are in the acute phase of chronic pancreatitis
  • Subjects with non-pancreatic malabsorption syndrome
  • Subjects with acute pancreatitis or ileus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (98)

Site Reference ID/Investigator# 59845

Aichi, Japan

Location

Site Reference ID/Investigator# 59933

Aichi, Japan

Location

Site Reference ID/Investigator# 59928

Akita, Japan

Location

Site Reference ID/Investigator# 59983

Amori, Japan

Location

Site Reference ID/Investigator# 59984

Amori, Japan

Location

Site Reference ID/Investigator# 59569

Ehime, Japan

Location

Site Reference ID/Investigator# 59938

Ehime, Japan

Location

Site Reference ID/Investigator# 59571

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59572

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59812

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59826

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59848

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59922

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59923

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59980

Fukuoka, Japan

Location

Site Reference ID/Investigator# 59932

Fukushima, Japan

Location

Site Reference ID/Investigator# 59935

Fukushima, Japan

Location

Site Reference ID/Investigator# 59930

Higashiibaraki, Japan

Location

Site Reference ID/Investigator# 59929

Hiroshima, Japan

Location

Site Reference ID/Investigator# 59968

Hiroshima, Japan

Location

Site Reference ID/Investigator# 59972

Hiroshima, Japan

Location

Site Reference ID/Investigator# 59827

Hokkaido, Japan

Location

Site Reference ID/Investigator# 59939

Hokkaido, Japan

Location

Site Reference ID/Investigator# 59969

Hokkaido, Japan

Location

Site Reference ID/Investigator# 59974

Hokkaido, Japan

Location

Site Reference ID/Investigator# 59981

Hokkaido, Japan

Location

Site Reference ID/Investigator# 59982

Hokkaido, Japan

Location

Site Reference ID/Investigator# 59576

Hyōgo, Japan

Location

Site Reference ID/Investigator# 59830

Hyōgo, Japan

Location

Site Reference ID/Investigator# 59847

Hyōgo, Japan

Location

Site Reference ID/Investigator# 59907

Hyōgo, Japan

Location

Site Reference ID/Investigator# 59908

Hyōgo, Japan

Location

Site Reference ID/Investigator# 59566

Ishikawa, Japan

Location

Site Reference ID/Investigator# 59911

Ishikawa, Japan

Location

Site Reference ID/Investigator# 59931

Kagoshima, Japan

Location

Site Reference ID/Investigator# 59564

Kanagawa, Japan

Location

Site Reference ID/Investigator# 59565

Kanagawa, Japan

Location

Site Reference ID/Investigator# 59819

Kanagawa, Japan

Location

Site Reference ID/Investigator# 59820

Kanagawa, Japan

Location

Site Reference ID/Investigator# 59823

Kanagawa, Japan

Location

Site Reference ID/Investigator# 59844

Kanagawa, Japan

Location

Site Reference ID/Investigator# 59858

Kanagawa, Japan

Location

Site Reference ID/Investigator# 59570

Kouchi, Japan

Location

Site Reference ID/Investigator# 59574

Kumamoto, Japan

Location

Site Reference ID/Investigator# 59854

Kurihara, Japan

Location

Site Reference ID/Investigator# 59821

Kyoto, Japan

Location

Site Reference ID/Investigator# 59910

Mie, Japan

Location

Site Reference ID/Investigator# 59979

Mie, Japan

Location

Site Reference ID/Investigator# 59849

Miyagi, Japan

Location

Site Reference ID/Investigator# 59851

Miyagi, Japan

Location

Site Reference ID/Investigator# 59857

Miyagi, Japan

Location

Site Reference ID/Investigator# 59975

Miyagi, Japan

Location

Site Reference ID/Investigator# 59976

Miyagi, Japan

Location

Site Reference ID/Investigator# 59977

Miyagi, Japan

Location

Site Reference ID/Investigator# 59937

Miyazaki, Japan

Location

Site Reference ID/Investigator# 59913

Nagano, Japan

Location

Site Reference ID/Investigator# 59825

Nagasaki, Japan

Location

Site Reference ID/Investigator# 59814

Nagoya, Japan

Location

Site Reference ID/Investigator# 59936

Nagoya, Japan

Location

Site Reference ID/Investigator# 59927

Nara, Japan

Location

Site Reference ID/Investigator# 59577

Okayama, Japan

Location

Site Reference ID/Investigator# 59567

Osaka, Japan

Location

Site Reference ID/Investigator# 59568

Osaka, Japan

Location

Site Reference ID/Investigator# 59575

Osaka, Japan

Location

Site Reference ID/Investigator# 59815

Osaka, Japan

Location

Site Reference ID/Investigator# 59822

Osaka, Japan

Location

Site Reference ID/Investigator# 59824

Osaka, Japan

Location

Site Reference ID/Investigator# 59829

Osaka, Japan

Location

Site Reference ID/Investigator# 59912

Osaka, Japan

Location

Site Reference ID/Investigator# 59914

Osaka, Japan

Location

Site Reference ID/Investigator# 59915

Osaka, Japan

Location

Site Reference ID/Investigator# 59934

Osaka, Japan

Location

Site Reference ID/Investigator# 59940

Osaka, Japan

Location

Site Reference ID/Investigator# 59573

Saga, Japan

Location

Site Reference ID/Investigator# 59556

Saitama, Japan

Location

Site Reference ID/Investigator# 59925

Saitama, Japan

Location

Site Reference ID/Investigator# 59555

Sapporo, Japan

Location

Site Reference ID/Investigator# 59810

Shiga, Japan

Location

Site Reference ID/Investigator# 59852

Shimane, Japan

Location

Site Reference ID/Investigator# 59855

Suwa, Japan

Location

Site Reference ID/Investigator# 59909

Tochigi, Japan

Location

Site Reference ID/Investigator# 59557

Tokyo, Japan

Location

Site Reference ID/Investigator# 59813

Tokyo, Japan

Location

Site Reference ID/Investigator# 59818

Tokyo, Japan

Location

Site Reference ID/Investigator# 59850

Tokyo, Japan

Location

Site Reference ID/Investigator# 59859

Tokyo, Japan

Location

Site Reference ID/Investigator# 59971

Tokyo, Japan

Location

Site Reference ID/Investigator# 59973

Tokyo, Japan

Location

Site Reference ID/Investigator# 59978

Tokyo, Japan

Location

Site Reference ID/Investigator# 59816

Toyama, Japan

Location

Site Reference ID/Investigator# 59970

Toyama, Japan

Location

Site Reference ID/Investigator# 59811

Wakayama, Japan

Location

Site Reference ID/Investigator# 59856

Yamagata, Japan

Location

Site Reference ID/Investigator# 59926

Yamagata, Japan

Location

Site Reference ID/Investigator# 59817

Yamaguchi, Japan

Location

Site Reference ID/Investigator# 59924

Yamaguchi, Japan

Location

Site Reference ID/Investigator# 59846

Yamanashi, Japan

Location

Site Reference ID/Investigator# 59828

Yokohama, Japan

Location

MeSH Terms

Conditions

Exocrine Pancreatic InsufficiencyPancreatitis, Chronic

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesPancreatitisChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Toshiaki Yamaguchi, BS Pharm

    Abbott

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 16, 2006

First Posted

November 17, 2006

Study Start

May 1, 2007

Primary Completion

August 1, 2009

Study Completion

August 1, 2009

Last Updated

July 28, 2011

Record last verified: 2011-07

Locations